Study on Early Lyme Neuroborreliosis

University Medical Centre Ljubljana50 enrolled

Overview

The purpose of this study is to determine clinical course and the sequelae of early Lyme neuroborreliosis after treatment with ceftriaxone.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Nervous System Lyme Borreliosis

Interventions

ceftriaxoneDRUG

ceftriaxone 2 g od i.v. for 14 days

Eligibility

Sex: ALLMin age: 15 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * erythema migrans within 4 months before neurologic involvement and pleocytosis in patients \>15 years old Exclusion Criteria: * pregnancy * lactation * history of adverse reaction to a beta-lactam antibiotic

Locations (1)

UMC Ljubljana, Department of Infectious Diseases

Ljubljana, Slovenia

RECRUITING

Outcomes

Primary Outcomes

Objective sequelae and post-treatment subjective symptoms in patients treated with ceftriaxone for early Lyme neuroborreliosis

Time frame: 1 year follow-up

Secondary Outcomes

Comparison of subjective symptoms between patients treated with ceftriaxone for early Lyme neuroborreliosis and control subjects without a history of Lyme borreliosis

Time frame: 1 year follow-up

Central Contacts

Dasa Stupica, MD

CONTACT

+38615222110 cerar.dasa@gmail.com

Franc Strle, MD

CONTACT

+38615222110 franc.strle@kclj.si

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.